Most Recent
AstraZeneca sues Pharmacor over plan to launch generic diabetes drug
AstraZeneca has sued Pharmacor over its plans to list a generic version of blockbuster diabetes drug Forxiga on the PBS, but the drug maker will have to defend the validity of the patent, which was struck down by a UK court last year. 
Zoetis hit with costs in bovine gene patent spat
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off. 
In TM battle with Zip, Firstmac tells High Court honest concurrent use test not subjective
More than just subjective intention is relevant to the defence of honest concurrent use in trade mark law, non-bank lender Firstmac has told the High Court in its dispute with buy now, pay later giant Zip Co.
Viral teeth whitener Hismile loses battle over trade mark
Social media darling Hismile has lost a challenge to a trade mark application by MySmile, after failing to prove its rival's mark was deceptively similar to its own viral dental care brand.
Merck fails to block Pfizer’s RSV vaccine trade mark
Merck KGaA has failed to block Pfizer’s 'Abrysvo' trade mark for its RSV vaccine, with a delegate finding no likelihood of confusion with the mark for Merck’s Mavenclad MS drug despite their visual similarities. 
Aristocrat’s trade secrets case against Light & Wonder settles for $190M
Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.
‘Paradigm shift’: Otsuka says High Court must reverse patent extension ruling
Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.
Drug makers back in court five years after settling case over Merck TM
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled. 
CSIRO wins appeal over gut-friendly wheat patent
The CSIRO has successfully appealed a decision that blocked the government agency’s application to patent a method of producing high-fibre wheat.
High Court sides with Bed Bath ‘N’ Table, says Full Court ‘conflated’ TM, consumer laws
The High Court has unanimously granted home retailer Bed Bath N’ Table’s appeal of a ruling that retailer House did not engage in misleading and deceptive conduct in setting up its Bed & Bath stores.